Stockreport

Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Cybin Inc. Common Shares  (CYBN) 
PDF TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (”Cybin” or the “Company”), a breakthrough Phase 3 clinical stage neuropsychiatry company co [Read more]